Inmune Bio's total assets for Q3 2025 were $33.36M, a decrease of -11.48% from the previous quarter. INMB total liabilities were $7.98M for the fiscal quarter, a -9.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.